Diet for Hypoglycemia

Hypoglycemia And Pregnancy News

Artificial pancreas holds promise for treating Type 1 diabetesTuesday, June 29, 2010 @ 4:24AMShawna Wood would like nothing better than to go back to bed for another 24 hours of perfect blood sugar control. The 50-year old Wilsonville, Ore. woman has Type 1 diabetes, and she recently took part in a clinical trial of an automated replacement for her pancreas, which stopped producing insulin 9 years ago.

New findings could lead to simple dietary solutions, possible therapeutics for gestational diabetesSunday, June 27, 2010 @ 11:53PMThe cause of diabetes during pregnancy is directly controlled by serotonin, a chemical produced by the body and normally known as a neurotransmitter, and is influenced by the amount of protein in the mother's diet early in pregnancy, according to new findings of an international team led by researchers at UCSF.

New Data Demonstrated Efficacy and Safety of Initial Combination Therapy with Welchol(R) (colesevelam HCl) and ...Saturday, June 26, 2010 @ 1:28PMPARSIPPANY, N.J., June 26 /PRNewswire/ -- Results of a new study demonstrated that initial combination therapy with Welchol® (colesevelam HCl) 3.75 g/d and metformin (initiated at 850 mg/d; uptitrated to 1700 mg/d thereafter) significantly improved glycemic and lipid control in drug-naive adult type 2 diabetes patients with high LDL cholesterol (LDL-C).

52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added To Metformin Was Non-Inferior To Titrated Glipizide When ...Saturday, June 26, 2010 @ 9:16AMOrlando, Florida, June 26, 2010 (ots/PRNewswire) - Bristol-Myers Squibb Company and AstraZeneca today announced results from a 52-week Phase 3b study ...

In a New Study, Treatment With JANUMET® (sitagliptin/metformin), Merck's Diabetes Medicine, Resulted In Significantly ...Saturday, June 26, 2010 @ 9:14AMNew data were presented at the American Diabetes Association (ADA) 70 th Annual Scientific Sessions from a study comparing JANUMET (sitagliptin/metformin) to pioglitazone.

52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added To Metformin Was Non-Inferior To Titrated Glipizide When ...Saturday, June 26, 2010 @ 9:02AMOrlando, Florida, June 26, 2010 (ots/PRNewswire) - Bristol-Myers Squibb Company and AstraZeneca today announced results from a 52-week Phase 3b study in adults with type 2 diabetes who had inadequate glycemic control on metformin therapy ...

52-Week Study Finds ONGLYZA (saxagliptin) When Added to Metformin Was Non-Inferior to Titrated Glipizide When Added to ...Saturday, June 26, 2010 @ 9:00AMORLANDO----Bristol-Myers Squibb Company and AstraZeneca today announced results from a 52-week Phase 3b study in adults with type 2 diabetes who had inadequate glycemic control on metformin therapy plus diet and exercise.

In a New Study, Treatment With JANUMET® (sitagliptin/metformin), Merck's Diabetes Medicine, Resulted In Significantly ...Saturday, June 26, 2010 @ 9:00AMWHITEHOUSE STATION, N.J.----New data were presented at the American Diabetes Association 70th Annual Scientific Sessions from a study comparing JANUMET to pioglitazone. In this study, JANUMET resulted in significantly greater blood sugar reductions in patients with type 2 diabetes compared with pioglitazone.

New Data Demonstrated Efficacy and Safety of Initial Combination Therapy with Welchol(R) (colesevelam HCl) and ...Saturday, June 26, 2010 @ 9:00AMResults of a new study demonstrated that initial combination therapy with Welchol® 3.75 g/d and metformin significantly improved glycemic and lipid control in drug-naive adult type 2 diabetes patients with high LDL cholesterol .  In the study, treatment with Welchol plus metformin significantly reduced mean A1C levels by 1.1 percent and LDL-C levels by 21 percent.  In addition, approximately ...